April 12, 11:19 PMVaccines ExaminerNorma Erickson
Last week, government officials in India called an immediate halt to any further HPV vaccinations until they complete an extensive investigation into allegations of unethical conduct by those involved in a ‘demonstration project’ aimed at vaccinating 32,000 girls, age 10-14, from Andhra Pradesh and Gujarat.
The suspension was called a few short hours after a group of health advocates presented a list of very serious ethical and moral concerns to their government officials, along with the demand for an investigation.
The government of India should be congratulated on their rapid and appropriate response to these citizen concerns. India has exhibited compassion for their citizens’ health and well-being above all else by agreeing to determine whether their concerns are valid, or not, before HPV vaccinations are resumed.
Unfortunately, the rest of the world does not seem to care as much for their citizens as does India. Similar concerns about HPV vaccine efficacy, benefits versus risks, questionable marketing campaigns, political ‘deals’, and the risk of serious adverse events, including death have been raised by at least 12 other countries around the world, with virtually no response.
Nearly identical questions have been brought forth by concerned citizens and health advocate groups in the United States, the United Kingdom, Netherlands, Australia, Germany, New Zealand, Argentina, Grance, Spain, Canada, Finland and Sweden. These people have received little, or no response from their respective governments.
All of these governments should be ashamed of themselves. Whether their citizens’ concerns are valid, or not, they should be investigated. This is not the first time pharmaceutical companies have unleashed a relatively unproven “remedy” on an unsuspecting public with disasterous results. Remember Vioxx, and the reported 300,000 unnecessary deaths by heart attack in the U.S.?
Why does the casualty count have to get that high before someone begins to listen?
India has a population of over 1 billion. There were only 14,000 girls vaccinated before the program was halted. It was halted in response to concerns raised after only 4 unexplained deaths and 120 serious systemic adverse reactions were brought to the attention of the authorities. In a population that size, these events could have easily been written off, as they seem to be in other countries. But, no—India took action.
The United States, for example, has a population of approximately 307 million. 29,323 young women participated in the clinical trials for Gardasil. During those trials, there were 37 deaths reported and 255 serious systemic adverse reactions. There were 463 reports of new medical conditions reported by participants that were “potentially indicative of systemic autoimmune disorder(s).” See verification here.
Almost 10 times the number of deaths, and over twice the amount of adverse events; not to mention the reports of new medical conditions.
Did the United States investigate to see if there was a problem with this? No! In a country that professes to take the lead regarding human rights issues, this is nothing short of criminal.
Women around the globe are tired of feeling they and thier families are “guinea pigs” for the pharmaceutical industry. They believe the practice needs to stop here and now.
Every country in the world needs to follow India’s lead and take their citizens’ health and well-being seriously. Investigate their concerns–independent of any input from anyone in, or with ties to, the pharmaceutical industry.
For the sake of humanity, at least make the effort to find out if their concerns are valid.
For more information, visit The Truth About Gardasil Website here, or the FDA website with information about reporting adverse reactions here.